Characterization of viremia at different stages of varicella-zoster virus infection
- PMID: 9700639
- DOI: 10.1002/(sici)1096-9071(199809)56:1<91::aid-jmv15>3.0.co;2-z
Characterization of viremia at different stages of varicella-zoster virus infection
Abstract
Varicella-zoster virus (VZV) viremia at different stages of infection was characterized. Different approaches were used, polymerase chain reaction (PCR), isothermal transcription based nucleic acid amplification (NASBA), and immunofluorescence to describe and quantitate viral infection of peripheral blood mononuclear cells (PBMC). In patients with acute varicella 200 to 5,000 copies of the viral genome in every 150,000 PBMC were found with quantitative competitive PCR (QCPCR). With NASBA, viral transcriptional activity was detected in these cells. RNA transcribed from the immediate early gene IE 63 as well as from the late gene 68 were found, indicating a productive infection. Glycoprotein gE specific immunofluorescence visualized by confocal laser scanning microscopy revealed that only 1 in 10,000 to 100,000 PBMC was infected. T and B lymphocytes as well as monocytes expressed viral protein on their surface. Similar results were obtained with PBMC from immunocompetent zoster patients. In some cases a transient viremia was found shortly after the onset of rash, although the viral load seemed to be lower than in patients with varicella. Examination of blood samples from 16 persons with postherpetic neuralgia (PHN) signs of viral replication in PBMC were not detected. In conclusion, the data suggest that VZV viremia is a frequent event in patients with varicella and zoster, but not in those with postherpetic neuralgia. Moreover, the results indicated that subclinical reactivations occur both in immunocompromised and immunocompetent individuals.
Similar articles
-
No acute varicella-zoster virus replication in peripheral blood mononuclear cells during postherpetic neuralgia.Acta Virol. 1999 Dec;43(6):337-40. Acta Virol. 1999. PMID: 10825921
-
Effect of viral load on the outcome of herpes zoster.J Clin Microbiol. 2007 Dec;45(12):3909-14. doi: 10.1128/JCM.00874-07. Epub 2007 Sep 12. J Clin Microbiol. 2007. PMID: 17855575 Free PMC article.
-
Acyclovir treatment prevents varicella-zoster virus replication in PBMC during viremia.New Microbiol. 1999 Oct;22(4):309-14. New Microbiol. 1999. PMID: 10555200
-
Varicella virus-mononuclear cell interaction.Adv Virus Res. 2003;62:1-17. doi: 10.1016/s0065-3527(03)62001-4. Adv Virus Res. 2003. PMID: 14719363 Review.
-
Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections.J Clin Virol. 2014 Dec;61(4):487-95. doi: 10.1016/j.jcv.2014.09.012. Epub 2014 Oct 2. J Clin Virol. 2014. PMID: 25453570 Review.
Cited by
-
Experimental infection of Cynomolgus Macaques (Macaca fascicularis) with human varicella-zoster virus.J Virol. 2012 Apr;86(7):3626-34. doi: 10.1128/JVI.06264-11. Epub 2012 Jan 18. J Virol. 2012. PMID: 22258257 Free PMC article.
-
Herpes simplex virus-1 and varicella-zoster virus latency in ganglia.J Neurovirol. 2003 Apr;9(2):194-204. doi: 10.1080/13550280390194000. J Neurovirol. 2003. PMID: 12707850 Review.
-
Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia.J Virol. 2003 Jun;77(12):6979-87. doi: 10.1128/jvi.77.12.6979-6987.2003. J Virol. 2003. PMID: 12768016 Free PMC article.
-
Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates.J Virol. 2000 Feb;74(4):1864-70. doi: 10.1128/jvi.74.4.1864-1870.2000. J Virol. 2000. PMID: 10644359 Free PMC article.
-
Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination.J Virol. 2002 Feb;76(4):1971-9. doi: 10.1128/jvi.76.4.1971-1979.2002. J Virol. 2002. PMID: 11799191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical